A conversation with David Ferguson, Business Leader, Sleep and Respiratory Care
David Ferguson, Business Leader, Sleep & Respiratory Care, joined Philips in March 2021. Since then, he has led the organization through the voluntary field safety notice of certain CPAP, BiPAP and Mechanical Ventilator devices. With the comprehensive test and research program for affected CPAP/BiPAP sleep therapy devices1 now complete, we asked him about what’s changed since the start of the field safety notice, what the test results mean for patients, and what to expect from Philips Respironics in the future.
1. First-generation DreamStation, System One and DreamStation Go devices